Company: MYGN
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0000899923-25-000066
Chunk: 2

Company: MYRIAD GENETICS INC
Filing Date: 2025-06-05
Form: 8-K
Item: Item 5.07
Chunk 2
---
 Named Executive Officers, as Disclosed in the Proxy Statement

  Votes           Votes          Votes          Broker     
  For             Against        Abstained      Non-Votes  
 ───────────────────────────────────────────────────────────
  67,755,156      5,847,659      80,243         8,547,127  

The advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved by stockholders.

Proposal No. 4: Approval of a Proposed Amendment to the 2017 Plan to Replenish the Share Pool for Equity Incentive Grants

  Votes           Votes          Votes          Broker     
  For             Against        Abstained      Non-Votes  
 ───────────────────────────────────────────────────────────
  69,476,724      4,175,785      30,549         8,547,127  

The stockholders voted to approve the proposed amendment to the 2017 Plan to increase the aggregate number of shares of common stock available for the grant of awards under the 2017 Plan by an additional 6.5 million shares.

ITEM 9.01 Financial Statements and Exhibits.